• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

(C226-3933)

1

Identification

C226-3933 C226-3933
Name C226-3933
Formula C18H13BrN2O3
MW 385.21
CAS No.
EINECS
Smiles C1C(O)=C(NC(C2C3CCC4C=CC=CC=4C=3ON=2)=O)C=C(Br)C=1
Synonyms
InChI InChI=1S/C18H13BrN2O3/c19-11-6-8-15(22)14(9-11)20-18(23)16-13-7-5-10-3-1-2-4-12(10)17(13)24-21-16/h1-4,6,8-9,22H,5,7H2,(H,20,23)
2

Introduction

C226-3933 is a novel cyclin-dependent kinase 8 (CDK8) inhibitor. The inhibition rate is 27.4±2.7 % at 10 μM. CDK8 gene expression correlates with increased mortality in colorectal, breast, and ovarian cancers and its overexpression is essential for the proliferation of cancer cells. Due to its key roles in oncogenesis, CDK8 has recently attracted considerable attention. Inhibitors of CDK8 offer a novel strategy for the treatment of various cancers.

Background Information

3

Protocol(Only for Reference)

Cell Experiment

Animal Experiment

4

Physical and Chemical Properties

Appearance: EBNumber:EB100692172

Storage condition

Solubility

5

Mechanism and Indication

Signaling Pathways Cell Cycle/DNA Damage
Target CDK
Research Area Cancer
Indications
6

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
7

Safety Data of C226-3933

8

Spectral Information

9

Suppliers List

Company Price and Availability Country/Region
AMEDCHEM CHINA
10

Related Products

Other Forms of

Name CAS No Formula MW

Recommended Compounds in CDK

Name CAS No Formula MW
LY2857785 1619903-54-6 C26H36N6O 448.6
THZ2 1604810-84-5 C31H28ClN7O2 566.0527
Palbociclib (isethionate) 827022-33-3 C26H35N7O6S 573.66
CDK9-IN-6 1391855-95-0 C27H37ClN6O2 513.07468
ML167 1285702-20-6 C19H17N3O3 335.36
AMG 925 1401033-86-0 C26H29N7O2 471.55
LDC000067 1073485-20-7 C18H18N4O3S 370.43
LEE011 (succinate hydrate) 1374639-79-8 C27H38N8O6X 570.64
LEE011 (succinate) 1374639-75-4 C27H36N8O5 552.63
LEE011 (hydrochloride) 1211443-80-9 C23H31ClN8O 471.0
LEE011 1211441-98-3 C23H30N8O 434.54
WHI-P180 (hydrochloride) 153437-55-9 C16H16ClN3O3 333.77
Wogonin 632-85-9 C16H12O5 284.26
1-NM-PP1 221244-14-0 C20H21N5 331.41
WHI-P180 211555-08-7 C16H15N3O3 297.31
THZ1 1604810-83-4 C31H28ClN7O2 566.05
Senexin A 1366002-50-7 C17H14N4 274.32
CDK4-IN-1 1256963-02-6 C22H29ClN8 440.97
Palbociclib (hydrochloride) 827022-32-2 C24H30ClN7O2 483.99
Purvalanol B 212844-54-7 C20H25ClN6O3 432.9

Recommended Compounds in Same Indication

Name CAS No Formula MW
11

Route of Synthesis

12

References

13

More Information

C226-3933

Tags: buy C226-3933 IC50 | C226-3933 price | C226-3933 cost | C226-3933 solubility | C226-3933 purchase | C226-3933 manufacturer | C226-3933 research buy | C226-3933 order | C226-3933 MSDS | C226-3933 chemical structure | C226-3933 Storage condition | C226-3933 molecular weight | C226-3933 mw | C226-3933 datasheet | C226-3933 supplier | C226-3933 cell line | C226-3933 NMR | C226-3933 MS | C226-3933 IR | C226-3933 solubility | C226-3933 Safe information | C226-3933 Qc and Spectral Information | C226-3933 Clinical Information | C226-3933 Clinical Trial | C226-3933 Route of Synthesis | C226-3933 storage condition | C226-3933 diseases and conditions | C226-3933 flash point | C226-3933 boiling point | C226-3933 melting point | C226-3933 storage condition | C226-3933 brand